Keyphrases
Multiple Sclerosis
100%
Multiple Sclerosis Treatment
43%
Relapsing-remitting multiple Sclerosis
23%
Intravenous Immunoglobulin (IVIg)
13%
Expanded Disability Status Scale
9%
Disease Duration
8%
Intravenous Immunoglobulin Therapy
7%
Disability
6%
Cognitive Performance
6%
Israel
6%
Progressive multiple Sclerosis
6%
Disease Progression
5%
COVID-19
5%
Experimental Autoimmune Encephalomyelitis
5%
Neuroscience
Multiple Sclerosis
94%
Relapsing Remitting Multiple Sclerosis
19%
Intravenous Immunoglobulin
10%
Gene Expression
10%
Expanded Disability Status Scale
8%
T Cell
6%
Magnetic Resonance Imaging
6%
Placebo
6%
Demyelinating Disease
6%
